Salute e Benessere

Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable…

RN3161, a novel siRNA developed through Rona's proprietary GAIA™ platform, targets INHBE to reduce fat while preserving lean mass, setting it apart from existing treatments. Engineered with optimized GalNAc-conjugated delivery and chemical modifications, it minimizes off-target risks and demonstrated more than 90% INHBE mRNA knockdown in monkeys with a low single dose. RN3161's long-lasting gene silencing supports Q6M to Q12M dosing, enhancing patient adherence and suitability for long-term…
PR Newswire
15/09/2025

Abzena Enhances AbZelectPRO™ Cell Line Offering with New GS Knockout Platforms

Campbell Bunce, CSO of Abzena, said, "At Abzena, we consistently strive to build stronger partnerships with our customers by offering them innovative solutions and technologies that meet their needs across the drug development supply chain. The addition of these new GS knockout cell lines to our AbZelectPRO™ CLD platform is a powerful combination that truly sets a new standard of excellence. We are thrilled to offer such a robust, scalable, and state-of-the-art offering to support our…
PR Newswire
15/09/2025

Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing…

AML represents about 30% of adult leukemias, with roughly 145,000 new cases annually worldwide. While chemotherapy induces remission in many patients, nearly half relapse. T-ALL, though rare, accounts for 15% of pediatric ALL and up to 25% in adults. Children often respond well to chemotherapy, but adult survival remains only ~40%. For relapsed or refractory patients, therapeutic options are extremely limited. Key preclinical findings of GYA01: The study confirms that CD84 is...
PR Newswire
15/09/2025

From Legacy to Innovation: Morphy Richards Refreshes at IFA 2025

Morphy Richards' innovations refreshed the brand and delivered standout performances at IFA 2025. The Fusion Kettle and Toaster Set earned the "Best of IFA" award from Gadget Flow. At the dedicated Chill Zone, the InfuseChill Flavoured Ice Maker received widespread acclaim for its customizable flavoured ice cubes, while the MixChill 3-in-1 Ice Maker fascinated visitors with its versatility in rapid ice production, crushing, and juicing. The Fully Automatic Coffee Machine garnered…
PR Newswire
15/09/2025

Philips intends to extend maturity of forward purchases of 4 million shares for…

Amsterdam, the Netherlands – Royal Philips(NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase programearlier announcedon June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this link. For further information, please...
Nasdaq GlobeNewswire
15/09/2025

Mycenax and SPERA PHARMA Forge Strategic Alliance to Streamline ADC Drug…

Founded in 2017 as a spin-off from Takeda Pharmaceutical Company's CMC Research Division, SPERA PHARMA is recognized for its deep experience in complex drug development, including process chemistry, formulation, analytical development, and GMP-compliant aseptic manufacturing. Building on Japan's leading pharmaceutical heritage, SPERA PHARMA is considered one of the country's top CDMOs, trusted by global partners for its technical excellence and integrated CMC solutions. Founded in 2017 as a...
PR Newswire
15/09/2025

EverBridge Group and Cosmotec Forge Landmark Partnership

Simultaneously, the partnership underscores Cosmotec's best-in-class digital commercialization platform, which accelerates market access for international medical devices and enables targeted engagement with clinical end-users. Simultaneously, the partnership underscores Cosmotec's best-in-class digital commercialization platform, which accelerates market access for international medical devices and enables targeted engagement with clinical end-users. "EverBridge Group's portfolio...
PR Newswire
15/09/2025

Radioligand Therapy (RLT) Market worth US$10.9 billion by 2035 with 13.2% CAGR |…

Browse in-depth TOC on "Radioligand Therapy (RLT) Market"420 - Tables62 - Figures445 - Pages Browse in-depth TOC on "Radioligand Therapy (RLT) Market" 420 - Tables 62 - Figures 445 - Pages By indication,the market is segmented into prostate cancer, neuroendocrine tumours (NETS), and other indications. In 2024, the prostate cancer segment accounted for the largest share of the market. This indication has a robust clinical need and rapid adoption of novel targeted therapies...
PR Newswire
13/09/2025

Lateral Flow Assay Components Market worth US$486.2 million by 2030 with 4.4%…

Browse in-depth TOC on 'Lateral Flow Assay Components Market' Browse in-depth TOC on 'Lateral Flow Assay Components Market' 220 - Tables 40 - Figures 260 - Pages By product,the lateral flow assay components market is divided into membranes, pads, and other parts. In 2024, membranes held the largest share because they are essential as the base material where test and control lines are placed to detect analytes. Their structural and chemical features directly influence assay...
PR Newswire
13/09/2025

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, Sept.12, 2025(GLOBE NEWSWIRE) --Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of SharesOutstanding Total number of voting rightsTotal voting...
Nasdaq GlobeNewswire
12/09/2025

Sanofi: Information concerning the total number of voting rights and shares -…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l’Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of €2,454,937,946 Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
12/09/2025

ZINZINO AB (PUBL.): ZINZINO ACQUIRES BODĒ PRO TO INCREASE DISTRIBUTION POWER IN…

The business has a total annual turnover of approximately USD 7 million. The collaboration with Zinzino is expected to add growth through the synergies that arise in the joint networks, combined with Zinzino's test-based product concept and Bodē Pro's innovative product range. Profitability through the transactions will thus be able to develop well by utilizing Zinzino's existing technical platform and organization. The business has a total annual turnover of approximatelyUSD 7 million...
PR Newswire
12/09/2025

Virbac: 2025 Half-year results

Solid revenue growth in the first half of 2025 of +5.6% at constant exchange rates and scopeAdjusted recurring operating income² of 18.3% as a ratio to revenue, in line with our expectationsDown compared to 2024 due to phasing and non-recurring effects2025 targets confirmedRevenue growth expected between 4% and 6% at constant rates and scopeAdjusted recurring operating income¹ expected around 16% CONSOLIDATED FIGURES AS OF JUNE 30 in € millionHY25...
Nasdaq GlobeNewswire
12/09/2025

Virbac : Half-yearly financial report 2025

Please find attached 2025 Half-yearly financial report of Virbac Attachment Half-Yearly Financial Report_2025
Nasdaq GlobeNewswire
12/09/2025

Virbac : Public release of the Half-Year Financial Report at 30 June 2025.

The Group released and filed its 2025 half-year financial report with the French “Autorité des marchés financiers”.The document is also available on the corporate website, at corporate.virbac.com, under “Investors”, “Financial Reports”. Attachment Public release of the Half-Year Financial Report_06.25
Nasdaq GlobeNewswire
12/09/2025

School Uniform Market Size Is Expected to Reach US$58.61 Billion By 2031, at A…

The report from The Insight Partners provides several stakeholders—including school uniform providers and school uniform manufacturers—with valuable insights into navigating this evolving market landscape and unlocking new opportunities. Thereport from The Insight Partnersprovides several stakeholders—including school uniform providers and school uniform manufacturers—with valuable insights into navigating this evolving market landscape and unlocking new opportunities. Check valuable...
PR Newswire
12/09/2025

Fluid Management Systems Market worth US$18.60 billion by 2030 with 7.0% CAGR |…

Browse in-depth TOC on "Fluid Management Systems Market"288 - Tables64 - Figures331 - Pages Browse in-depth TOC on "Fluid Management Systems Market" 288 - Tables 64 - Figures 331 - Pages By product type,Systems hold the largest market share of the fluid management systems (FMS) market because they offer comprehensive and reliable solutions for fluid irrigation, suction, warming, and waste management during surgeries. Their widespread adoption in hospitals and surgical…
PR Newswire
12/09/2025

Cystoscopy and Ureteroscopy Market is Expected to Reach US$ 729.30 Million By…

The report from The Insight Partners, therefore, provides several stakeholders—including cystoscopy and ureteroscopy equipment manufacturers, cystoscopy and ureteroscopy systems distributors, and others—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. The report from The Insight Partners, therefore, provides several stakeholders—including cystoscopy and ureteroscopy equipment manufacturers, cystoscopy and ureteroscopy…
PR Newswire
12/09/2025

WFH mobilizes global community to achieve milestone revisions to WHO EML

"The updates to the WHO EML mean that thousands of PWBDs now have greater hope for a better future. The WFH is proud to have led a united global effort to make this milestone possible. Together, we are shaping a future where our vision of Treatment for All can become a reality."—Cesar Garrido, President, WFH "The updates to the WHO EML mean that thousands of PWBDs now have greater hope for a better future. The WFH is proud to have led a united global effort to make this milestone…
PR Newswire
12/09/2025

Alkermes Appoints Joshua Reed as Chief Financial Officer

Mr. Reed brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics, a then publicly-traded biotechnology company. Prior to that, he was the CFO at Aldeyra Therapeutics. Earlier in his career, Mr. Reed spent more than a decade at Bristol Myers Squibb, culminating in his role as Vice President and Head of Finance Operations for the U.S. and Puerto Rico. His experience also…
PR Newswire
12/09/2025

Pulnovo Medical Receives two IDE approvals for PADN system's clinical trials…

PADN has received FDA HUD designation, is approved by the NMPA, and is CE-marked, meaning it meets high safety and efficacy standards globally. Pulmonary Artery Denervation (PADN) offers more options for both Group I pulmonary arterial hypertension patients with limited response to existing drug therapies and Group II pulmonary hypertension patients, who currently have no specifically approved treatment. With over 1,000 clinical applications across countries such as Portugal, Georgia, Singapore…
PR Newswire
12/09/2025

Bacteriological Testing Market worth 37.26 billion USD by 2030- Exclusive Report…

Browse in-depth TOC on "Bacteriological Testing Market" Browse in-depth TOC on "Bacteriological Testing Market" 547– Tables 61– Figures 407– Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=238062451 The pharmaceutical industry is projected to register the highest growth during the forecast period. By end-use industry, the pharmaceutical segment is projected to be the fastest-growing market during the forecast period. This trend...
PR Newswire
12/09/2025

Folding Furniture Market Projected to Surpass USD 7B by 2030 Amid Growing…

The surge in compact housing, particularly in densely populated cities, has fueled the adoption of folding chairs, tables, and beds that maximize utility in limited areas. Growing numbers of students, young professionals, and nuclear families are driving this preference for portable and multifunctional products. While folding furniture is often associated with temporary or low-cost use, consumer perception is changing rapidly. Premium folding products now cater to style-conscious buyers…
PR Newswire
12/09/2025

Kanazawa University research: Thermal trigger

The scientists worked with so-called elastin-like polypeptides (ELPs), biopolymers composed of repeated amino acid building blocks. ELPs are soluble below a certain temperature; above the temperature threshold, they group into coacervate droplets. An ELP's transition temperature depends on the precise composition of its monomer building block, as well as on its number of monomers. By changing these characteristics, the transition temperature of an ELP can be fine-tuned, which offers the…
PR Newswire
12/09/2025
Altri  Comunicati